Valuation: Shouyao Holdings (Beijing) Co., LTD.

Capitalization	6.35B 933M 805M 736M 696M 1.29B 89.93B 1.31B 8.75B 3.42B 42.55B 3.5B 3.43B 149B	P/E ratio 2024	-20.9x	P/E ratio 2025	-39.9x
Enterprise value	5.69B 836M 722M 660M 624M 1.15B 80.6B 1.17B 7.85B 3.06B 38.13B 3.14B 3.07B 133B	EV / Sales 2024	935x	EV / Sales 2025	520x
Free-Float	27.12%	Yield 2024 *	-	Yield 2025	-

* Estimated data More valuation ratios

Chart: Shouyao Holdings (Beijing) Co., LTD.

Timeframe

Style

Dynamic Chart

Latest news : Shouyao Holdings (Beijing) Co., LTD.

04-17	Shouyao Holdings Co., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
04-15	Shouyao Holdings Co., LTD. announced that it expects to receive CNY 300 million in funding	CI
02-05	Shouyao Holdings Obtains Approval for Cancer Drug Trial	MT
01-30	Shouyao Holdings Co., LTD. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
12-12	Shouyao Holdings plans to seek Hong Kong listing	RE
30/10/25	Shouyao Holdings Co., LTD. Reports Earnings Results for the Nine Months Ended September 30, 2025	CI
27/08/25	Shouyao Holdings Co., LTD. Reports Earnings Results for the Half Year Ended June 30, 2025	CI
28/04/25	Shouyao Holdings Gets Ethical Approval for Tumor Clinical Trials	MT
27/04/25	Shouyao Holdings Co., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
17/01/25	Shouyao Holdings Co., LTD. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
27/10/24	Shouyao Holdings Co., LTD. Reports Earnings Results for the Nine Months Ended September 30, 2024	CI
25/08/24	Shouyao Holdings Co., LTD. Reports Earnings Results for the Half Year Ended June 30, 2024	CI
28/04/24	Shouyao Holdings Co., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

More news

Managers and Directors: Shouyao Holdings (Beijing) Co., LTD.

Manager	Title	Age	Since
Wen Jun Li CEO	Chief Executive Officer	59	31/12/2020
Ya Jie Wang DFI	Director of Finance/CFO	56	30/04/2019
Ying Hui Sun CTO	Chief Tech/Sci/R&D Officer	46	31/07/2010

Director	Title	Age	Since
Wen Jun Li CHM	Chairman	59	31/03/2016
Xin He Xu BRD	Director/Board Member	52	31/07/2020
Jing Han Wang CHM	Chairman	37	31/07/2020

More insiders

Other Biotechnology & Medical Research

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
SHOUYAO HOLDINGS (BEIJING) CO., LTD.	+0.73%	+0.87%	+24.80%	-33.39%	926M
LONZA GROUP AG	+0.26%	+5.20%	-12.54%	-14.45%	43.7B
BEONE MEDICINES AG	+0.59%	+1.49%	+30.73%	+27.72%	34.32B
REVOLUTION MEDICINES, INC.	+2.61%	+2.58%	+295.79%	+474.48%	31.96B
IQVIA HOLDINGS INC.	-2.33%	-1.44%	+22.54%	-16.62%	28.62B
CELLTRION, INC.	+5.69%	-0.47%	+26.97%	+19.06%	25.12B
ASCENDIS PHARMA A/S	+1.25%	-0.46%	-	-	14.99B
REGENCELL BIOSCIENCE HOLDINGS LIMITED	+0.69%	+3.27%	+154.46%	+4,299.92%	13.54B
EUROFINS SCIENTIFIC SE	+0.77%	+5.39%	+10.68%	+3.13%	12.71B
IONIS PHARMACEUTICALS, INC.	+1.12%	-0.12%	+125.64%	+85.68%	12.4B
Average	+1.18%	+0.55%	+75.45%	+538.39%	21.83B
Weighted average by Cap.	+1.23%	+0.51%	+74.23%	+367.90%

See all sector performances

Shouyao Holdings Co Ltd is a China-based company mainly engaged in the discovery and development of innovative small molecule therapies in the field of cancer. The Company's independently developed product pipeline mainly includes SY-707, SY-3505, SY-5007, SY-5933, SY-4798, SY-4835, SY-9453, SY-7166, SY-12321, and SY-14556. The company's collaborative developed product pipeline mainly includes CT-1139/TQ-B3139, CT-1995/TQ05105, CT-2755/TQ-B3454, CT-034/TQ-B3234, CT-2426/TQ-B3455, CT-133/CSPCHA115, CT-1495/TQ-B3395, CT-1803/TQ-B3303, CT-3417/TQ-B3558, CT-3872/TQ-B3811 and CT-4460/TQ-B3617. The Company operates its businesses in the domestic market.

Employees

172

Sector

Biotechnology & Medical Research

More about the company

Quotes

Date	Price	Change	Volume
20/05/26	42.67 ¥	+0.73%	2,237,696
20/05/26	42.36 ¥	+0.31%	1,935,371
19/05/26	42.23 ¥	+2.25%	1,405,329
18/05/26	41.30 ¥	-1.05%	1,577,885
15/05/26	41.74 ¥	+0.07%	1,510,403

End-of-day quote Shanghai S.E.

More quotes

Income Statement and Estimates

More financial data

Annual profits - Rate of surprise

Company calendar

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

End-of-day quote Shanghai S.E. Other stock markets 21/05/2026			5-day change	1st Jan Change
42.67 ^CNY	+0.73%		+0.87%	+22.83%

1 day	+0.73%
1 week	+0.87%
Current month	+4.46%
1 month	+1.72%
3 months	+9.83%
6 months	+3.74%
Current year	+22.83%

1 week	40.5	44.3
1 month	37.31	44.92
Current year	33.63	46.25
1 year	33.47	56.86
3 years	25.52	64.99
5 years	17.52	68
10 years	17.52	68

	2024	2025
Net sales	3.94M 579K 500K 457K 432K 799K 55.86M 813K 5.44M 2.12M 26.43M 2.17M 2.13M 92.25M	8.67M 1.27M 1.1M 1.01M 951K 1.76M 123M 1.79M 11.96M 4.67M 58.11M 4.78M 4.68M 203M
Net income	-212M -31.16M -26.89M -24.59M -23.24M -42.95M -3B -43.71M -292M -114M -1.42B -117M -114M -4.96B	-129M -18.94M -16.35M -14.95M -14.13M -26.11M -1.83B -26.57M -178M -69.43M -864M -71.07M -69.56M -3.01B
Net Debt	-754M -111M -95.62M -87.44M -82.65M -153M -10.68B -155M -1.04B -406M -5.05B -416M -407M -17.64B	-658M -96.76M -83.51M -76.36M -72.19M -133M -9.33B -136M -908M -355M -4.41B -363M -355M -15.4B

Shouyao Holdings (Beijing) Co., LTD. Share Price

Equities

688197

CNE1000062V6

Biotechnology & Medical Research

Valuation: Shouyao Holdings (Beijing) Co., LTD.

Chart: Shouyao Holdings (Beijing) Co., LTD.

Latest news : Shouyao Holdings (Beijing) Co., LTD.

Quotes and Performance

Course Extremes

Managers and Directors: Shouyao Holdings (Beijing) Co., LTD.

Other Biotechnology & Medical Research

Financials

Company Profile

Quotes

Income Statement and Estimates

Annual profits - Rate of surprise